share_log

Illumina | SC 13G: Statement of acquisition of beneficial ownership by individuals-Illumina, Inc.(14.5%)

Illumina | SC 13G: Statement of acquisition of beneficial ownership by individuals-Illumina, Inc.(14.5%)

Illumina | SC 13G：超过5%持股股东披露文件-Illumina, Inc.(14.5%)
美股SEC公告 ·  08/14 16:53
Moomoo AI 已提取核心信息
Illumina, Inc., a biotechnology company based in Delaware, has filed a Schedule 13G with the U.S. Securities and Exchange Commission on August 14, 2024, indicating a significant ownership stake in GRAIL, Inc. following a corporate spin-off. On June 24, 2024, Illumina completed the distribution of approximately 85.5% of GRAIL's common stock to Illumina's shareholders. Post spin-off, Illumina retained direct ownership of 4,502,126 shares, representing 14.5% of GRAIL's outstanding common stock. The filing also notes that Illumina has granted GRAIL a proxy to vote its shares in alignment with the majority of GRAIL's stockholders. The reported ownership percentage is based on 31,049,148 shares of GRAIL's common stock outstanding as of August 11, 2024.
Illumina, Inc., a biotechnology company based in Delaware, has filed a Schedule 13G with the U.S. Securities and Exchange Commission on August 14, 2024, indicating a significant ownership stake in GRAIL, Inc. following a corporate spin-off. On June 24, 2024, Illumina completed the distribution of approximately 85.5% of GRAIL's common stock to Illumina's shareholders. Post spin-off, Illumina retained direct ownership of 4,502,126 shares, representing 14.5% of GRAIL's outstanding common stock. The filing also notes that Illumina has granted GRAIL a proxy to vote its shares in alignment with the majority of GRAIL's stockholders. The reported ownership percentage is based on 31,049,148 shares of GRAIL's common stock outstanding as of August 11, 2024.
生物技术公司 illumina，总部位于特拉华州，于2024年8月14日向美国证券交易委员会提交了13G表格，表示在 GRAIL 公司的一次企业分拆后持有重要的所有权。2024年6月24日，illumina 完成了向其股东分配 GRAIL 普通股约85.5%的股份。分拆后，illumina 直接持有4502126股 GRAIL 普通股，占 GRAIL 出色普通股的14.5％。文件还指出，illumina 向 GRAIL 授权代理投票，以与 GRAIL 大多数股东的利益一致。所报告的所有权百分比基于2024年8月11日 GRAIL 普通股的31049148股。
生物技术公司 illumina，总部位于特拉华州，于2024年8月14日向美国证券交易委员会提交了13G表格，表示在 GRAIL 公司的一次企业分拆后持有重要的所有权。2024年6月24日，illumina 完成了向其股东分配 GRAIL 普通股约85.5%的股份。分拆后，illumina 直接持有4502126股 GRAIL 普通股，占 GRAIL 出色普通股的14.5％。文件还指出，illumina 向 GRAIL 授权代理投票，以与 GRAIL 大多数股东的利益一致。所报告的所有权百分比基于2024年8月11日 GRAIL 普通股的31049148股。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息